PULSE BIOSCIENCES (PLSE) COO Liane Teplitsky Buys 2,025 Shares

What Happened
Liane Rae Teplitsky, Chief Operating Officer of PULSE BIOSCIENCES (PLSE), made open-market purchases totaling 2,025 shares across two days: 1,024 shares on 2026-08-31 and 1,001 shares on 2026-09-01. The purchases were at about $48.76–$48.80 (weighted) on Aug 31 and $49.95 on Sep 1, for a combined reported cost of approximately $99,971. These were purchases (buying stock), which many investors view as a more informative signal than sales, though motivations are not disclosed.

Key Details

• Transaction dates and prices:
  • 2026-08-31: 1,024 shares at $48.80 (reported total $49,971; weighted prices that day ranged $48.76–$48.80 per F3)
  • 2026-09-01: 1,001 shares at $49.95 (reported total $50,000)
• Total shares bought: 2,025; total reported value: ~$99,971.
• Shares owned after transaction: Not disclosed in the filing.
• Footnotes of note:
  • F1: Trades occurred during an open trading window and in compliance with applicable laws.
  • F2: Fractional shares were rounded down to whole shares.
  • F3: Aug 31 price is a weighted average of multiple trades that day ($48.76–$48.80).
  • F4: Same-day, same-price trades were aggregated and reported on a single line.
• Filing timeliness: Form 4 filed 2026-09-02 (timely under the two-business-day requirement).

Context
These were straightforward open-market purchases (transaction code P). The filing provides procedural footnotes but no 10b5-1 plan or tax-withholding notes. Purchases by executives can be interpreted by some investors as a positive signal, but the filing does not state the insider’s reasons.